Form 4: Inspire Medical Systems Director Acquires Shares in Lieu of Cash Fees
SEC Form 4 Filing
Director Casey M. Tansey acquired 62 shares of Inspire Medical Systems, Inc. common stock in lieu of cash fees at a price of $231.74 per share.
Summary
- On April 12, 2024, Casey M. Tansey, a director of Inspire Medical Systems, Inc., acquired 62 shares of common stock.
- The shares were received in lieu of cash fees, as per the company's Non-Employee Director Compensation Policy.
- The price per share was $231.74.
- Following the transaction, Tansey directly owns 19,544 shares of common stock.
- Tansey also indirectly owns 500 shares through The Kimberly Tansey Irrevocable Trust and 500 shares through The Kylie Tansey Irrevocable Trust.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. A director acquiring shares, even in lieu of cash, suggests confidence in the company's future prospects. However, it's a routine transaction and not a major event.
Positives
- The director's acquisition of shares demonstrates confidence in the company.
- Using stock in lieu of cash fees can conserve company cash resources.
Industry Context
Director share acquisitions are common and often viewed positively, reflecting alignment between management and shareholder interests. The use of stock-based compensation is also a common practice to conserve cash and incentivize performance.
Comparison to Industry Standards
- Stock-based compensation for directors is a common practice among publicly traded companies, particularly in growth-oriented sectors like medical technology.
- Companies like Medtronic and Boston Scientific also utilize stock options and restricted stock units as part of their director compensation packages.
- The specific amount and terms of stock-based compensation vary depending on the company's size, performance, and compensation philosophy.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with shareholder value.
- It has a minor positive impact on the company's cash flow as it reduces the need for cash compensation.
Key Dates
| Date | Description |
|---|---|
| 04/12/2024 | Date of the transaction where Casey M. Tansey acquired shares of common stock. |
| 04/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.